Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9391193 | Journal of Vascular and Interventional Radiology | 2005 | 5 Pages |
Abstract
Renal radiofrequency (RF) ablation therapy is a safe and effective therapy for small renal cell carcinoma. Although the risk of complications is low, the potential for ureteral or calyceal injury does increase in the case of a centrally located lesion. A retrograde cold dextrose pyeloperfusion technique was designed to protect the collecting system in a patient who underwent percutaneous RF ablation of a central tumor of the left kidney.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Tze M. MD, Philip MD, Henry C. MD, Debra A MD, Peter R. MD,